YD Bio Limited Ordinary Shares Accounts Payable

YD Bio Limited Ordinary Shares (YDES) currently reports a accounts payable of $410K as of December 2025. That compares with $27K in the prior-year period — up 1445.4% year over year. Use the charts on this page to explore YD Bio Limited Ordinary Shares's accounts payable history and peer comparisons.

YD Bio Limited Ordinary Shares's accounts payable increased from $27K to $410K — a 1445.4% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

YD Bio Limited Ordinary Shares reported $410K in accounts payable as of December 2025. That compares with $27K in the prior-year period — up 1445.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $410K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for YD Bio Limited Ordinary Shares, and consider following YDES for alerts when major investors trade the stock.

YD Bio Limited Ordinary Shares is classified in the Healthcare sector. On accounts payable, it currently shows $410K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing YDES with unrelated industries.